hrp0098p3-178 | Growth and Syndromes | ESPE2024

Chromosomal abnormalities and phenotypic features in algerian paediatric population with Turner Syndrome.

Aboura Rawda , Ladjouze Asmahane , Ouarezki Yasmine , Djermane Adel , Mohammedi Kahina , Kherra Sakina , Bouferoua Fadila , Nora Fedala-Haddam Soumia , Laraba Abdenour , Bouzerar Zair

Turner syndrome (TS) is the most common genetic disorder occurring in 1 / 2500 live-borne girls. It’s characterized by complete or partial loos of one X chromosome associated with short stature and premature ovarian failure. Morbimortality are increased in TS and related to cardiovascular (CV) disease. The aim of this study was to investigate the karyotypes and the phenotypes of a paediatric population with Turner Syndrome.Methods:...

hrp0095p2-198 | Growth and Syndromes | ESPE2022

Efficacity of Growth Hormone Treatment in Children with Intrauterine Growth Restriction IUGR

Baz Ouidad , Aboussamaane Souha , Benachour Soumia , Mimoun Sofia

WHO defines children born with intrauterine growth restriction (IUGR) as those with a birth weight below the 10th percentile of recommended birth weight by sex for gestational age. When gestational age is not available, a birth weight < 2500 g should be considered. The adult height in IUGR children treated with GH depends mainly on the duration of treatment and the age of initiation. Early diagnosis and early management before puberty are therefore imperative.<p class="...

hrp0089p3-p403 | Diabetes &amp; Insulin P3 | ESPE2018

Epidemiology, Demographic Criteria and Risk Factors in Type 1 DM Egyptian Children; A Single Center Study

Badawi Nora , Shaalan Yomna

Introduction and Objectives: Type 1 DM is a chronic metabolic disease. Its incidence is rising worldwide. We studied demographic criteria, risk factors and epidemiology of children with type 1 DM attending our diabetes control clinic.Methods: This cross sectional study was conducted over 3214 children between 1–18 years who are diagnosed with type 1 diabetes and following up in DEMPU clinic, Cairo university children’s hospital. Between April 2...

hrp0095p2-86 | Diabetes and Insulin | ESPE2022

Type 1 diabetes in children: What are the particularities?

Ourdi Amal , Hajar Charif , Latifa Yagoubi , Najoua Messaoudi , Soumia Berrabeh , Siham Rouf , Hanane Latrech

Introduction: Children’s type 1 diabetes is a rare entity, its prevalence is still poorly known, which makes its diagnosis, therapeutic management and prognosis increasingly difficult and uncodified. The purpose of our study is to report the experience of the Endocrinology - Diabetology and Nutrition Department in the management of diabetes in children.Methods: This is a retrospective, descriptive study including 1...

hrp0092p2-87 | Diabetes and Insulin | ESPE2019

Glycemic Control in Egyptian Adolescent Girls with Type 1 DM

Shaalan Yomna , Badawi Nora , Soliman Aliaa

Background: Adolescents with Type 1 Diabetes (T1D) have worse metabolic control than preadolescent children due to poor adherence with medications and insulin resistance related to puberty hormones. Adolescent girls are at a particular risk for poor control as insulin sensitivity decreases in the luteal phase and menstrual cycle. Progesterone, secreted in the second half of the cycle, may cause an increase in appetite and caloric intake....

hrp0097p1-327 | Growth and Syndromes | ESPE2023

Growth results after GH treatment of children with juvenile idiopathic arthritis

Noumi Mustapha , Akretche Nora , Boukari Rachida

Introduction: Short stature is a very common complication of juvenile idiopathic arthritis (JIA). Chronic inflammation, long-term corticosteroid therapy, hepatic impairment and malnutrition can reduce the biological effects of IGF-1 and GH. Growth hormone (GH) treatment may improve height growth outcomes in patients with severe juvenile idiopathic arthritis (JIA). The aim of the study was to assess the response to growth hormone (GH) treatment in patients with...

hrp0089p2-p257 | Growth &amp; Syndromes P2 | ESPE2018

Clinical Effectiveness and Cost-Effectiveness of Somatropin Treatment for Short Children in Egypt: Analysis of 1-Year Data

Ibrahim Amany , Atef Abeer , Badawy Nora , Helmy Eatemad

Recombinant human growth hormone (rhGH) is approved for short stature associated with growth hormone deficiency (GHD), idiopathic short stature (ISS), Turner syndrome (TS), multiple pituitary hormone deficiencies (MPHD), Silver Russell syndrome (SRS) and being born small for gestational age non syndromic (SGA). Objectives: To assess the clinical effectiveness and cost-effectiveness of rhGH in children with GHD, TS and those born SGA. Methods: ...

hrp0086p2-p86 | Adrenal P2 | ESPE2016

Congenital Adrenal Hyperplasia Revealed by Adrenal Nodules

El Mahdi Haddam Ali , Soumeya Fedala Nora , Meskine Djamila

Background: Congenital adrenal hyperplasia (CAH) is a pathology with a genetic deficiency of one of the enzymes of steroidogenesis. It is due to 21 –Ohase deficiency in 90–95% of cases. The complete deficiency of this enzyme is responsible for the classic form (sexual ambiguity at birth with or without salt loss). While the partial deficiency results in a polymorphic clinical presentation occurring in childhood or adolescence. In rare neglected cases, the diagnosis i...

hrp0086p2-p578 | Perinatal Endocrinology P2 | ESPE2016

Primary Hyperparathyroidism in Children and Adolescents: About a Series of Ten Patients

Fedala Nora Soumeya , Haddam Ali El Mahdi , Meskine Djamila

Background: Primary hyperparathyroidism (PHPT) in children and adolescents is rare. Sporadic forms are more frequent and correspond, usually, with an adenoma (73%). Most rare familial forms (7%) are related to hyperplasia. They may be isolated or integrate with multiple endocrine neoplasia (MEN). The PHPT is revealed mostly by chronic bone pain increased by pressure, walking and exercise, arthralgia, growth failure and nonspecific late deformities.Object...

hrp0086p2-p686 | Growth P2 | ESPE2016

Neonatal Characteristics of GH Deficiency in 107 Children

Fedala Nora Soumeya , Haddam Ali El Mahdi , Meskine Djamila

Background: GH deficiency (GHD) rarely reveals at birth. Pregnancy is proceeding normally. The size and weight are generally normal and the birth occurs at terms. In some cases, neonatal markers and other pituitary deficits are present and allow early diagnosis.Objective and hypotheses: Report neonatal characteristics of GHD.Method: 107 children GHD were followed. The interrogation noted the progress of pregnancy, childbirth, weigh...